Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
38
EML Quote, Financials, Valuation and Earnings
Last price:
$26.50
Seasonality move
:
4.23%
Day range:
$26.55 - $26.90
52-week range:
$23.15 - $35.78
Dividend yield:
1.64%
P/E ratio:
15.68x
P/S ratio:
0.60x
P/B ratio:
1.37x
Volume:
5.9K
Avg. volume:
7.7K
1-year change:
-5.68%
Market cap:
$164.8M
Revenue:
$272.8M
EPS (TTM):
-$1.39
The Eastern Number of Institutional Trades
The Eastern Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$80M
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$197.5M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
The Eastern Institutional Ownership
-
What Percentage Of EML Is Owned by Institutions?
-- of EML is owned by institutions.
-
How Many Institutions Own EML Shares?
The Eastern stock is owned by 155 institutional shareholders at this time.
-
Have Institutions Been Buying EML Stock?
Yes, institutions have bought 621.9K shares of EML in the last quarter.
-
Have Institutions Been Selling EML Stock?
Yes, institutions have sold 3.9M shares of EML over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
